Increased Mortality Rate in Patient with Frothy Sputum After Tof Total Correction Surgery
DOI:
https://doi.org/10.59141/jrssem.v1i10.183Keywords:
frothy sputum; CHD; TOF; down syndrome; MAPCAs; myocardial dysfunctionAbstract
Tetralogy of Fallot (TOF) is the most common congenital heart disease. The most common risk factor for TOF is Down syndrome(DS). There are two management approaches for TOF: medication and operation. Operation/surgical treatment is consisted of palliative shunt and definitive repair. In several case patients with TOF develop collaterals or major aortopulmonary collateral arteries (MAPCAs), which can lung overflow can be initiated after surgery procedure was completed. This causes the CPB time in the repair operation to be long so that the risk of RV/LV dysfunction due to ischemic use of the CPB machine is very high. Frothy sputum is the one of signs of lung injury that related to left and/or right ventricular dysfunction, it may increased mortality in patients TOF repaired. The aim of this study was to identify frothy sputum associated with mortality in patient repaired of TOF. This study is cross-sectional study. We collect data retrospectively through medical record list from 2019 to 2020. In our study, there were 32 patients data included, consisted with more dominant male (n = 22) compare to female (n = 10). It was found that 7 female patients and 9 male patients experienced frothy sputum after TOF repair surgery. There are association not only mortality (p-value 0.033) but also frothy sputum with pulmonary regurgitation (p-value 0.049). Although any result of the study and weakness described previously, the study can be as basis for futher research so that an appropiate guideline can be established to deal frothy sputum in patients TOF repaired.
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Suprayitno Wardoyo, Dhama Shinta Susanti, Aflah Dhea Bariz Yasta, Rendy Agustian, Laksana Paduan Wilangsoka
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International. that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.